Pharmacologic Principles and Practicalities

Avery's Diseases of the Newborn

Volumn , Issue , 2005, Pages 427-437

  Ward, Robert M ^a,b   Lugo, Ralph A ^c  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH HOSPITAL   (United States)

^c UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 60349083552     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-072169347-7.50035-4     Document Type: Chapter

References (32)

1. American Academy of Pediatrics, Committee on Drugs The transfer of drugs and other chemicals into human breast milk. Pediatrics 2001, 108:776.
2. ASHP Understanding and preventing drug misadventures. Proceedings of a conference. Chantilly, Virginia, October 21-23, 1994. Am J Health Syst Pharm 1995, 52:369.
3. ASHP guidelines on preventing medication errors in hospitals. Am J Hosp Pharm 1993, 50:305.
4. Aperia A, Broberger O, Elinder G, et al. Postnatal development of renal function in preterm and full-term infants. Acta Paediatr Scand 1981, 70:183.
5. Aranda JV, Cohen S, Neims AH Drug utilization in a newborn intensive care unit. J Pediatr 1976, 89:315.
6. Aranda JV, Collinge JM, Clarkson S Epidemiologic aspects of drug utilization in a newborn intensive care unit. Semin Perinatol 1982, 6:148.
7. Aranda JV, Portuguez-Malavasi A, Collinge JM, et al. Epidemiology of adverse drug reactions in the newborn. Dev Pharmacol Ther 1982, 5:173.
8. Aranda JV Factors associated with adverse drug reactions in the newborn. Pediatr Pharmacol 1983, 3:245.
9. Boreus LO Principles of Pediatric Pharmacology 1982, Churchill Livingstone, New York.
10. Burns LE, Hodgman JE, Cass AB Fatal circulatory collapse in premature infants receiving chloramphenicol. N Engl J Med 1959, 261:1318.
11. Gauntlett IS, Fisher DM, Hertzka RE, et al. Pharmacokinetics of fentanyl in neonatal humans and lambs: Effects of age. Anesthesiology 1988, 69:683.
12. Gibaldi M, Perrier D Pharmacokinetics 1982, Marcel Dekker, New York. 2nd ed.
13. Gould T, Roberts RJ Therapeutic problems arising from the use of the intravenous route for drug administration. J Pediatr 1979, 95:465.
14. Greenblatt DJ, Koch-Weser J Clinical pharmacokinetics (First of two parts). N Engl J Med 1975, 293:702.
15. Greenblatt DJ, Koch-Weser J Clinical pharmacokinetics (Second of two parts). N Engl J Med 1975, 293:964.
16. Kauffman RE The clinical interpretation and application of drug concentration data. Pediatr Clin North Am 1981, 28:35.
17. Koehntop DE, Rodman JH, Brundage DM, et al. Pharmacokinetics of continuous infusion of fentanyl in neonates. Anesth Analg 1986, 65:227.
18. McCracken GH Aminoglycoside toxicity in infants and children. Am J Med 1986, 80(Suppl 6B):172.
19. Mirkin BL Pharmacodynamics and drug disposition in pregnant women, in neonates, and in children. Clinical Pharmacology: Basic Principlesin Therapeutics 1978, 127. Macmillan, New York. 2nd ed. K.L. Melmon, H.F. Morrelli (Eds.).
20. Morselli PL, Franco-Morselli R, Bossi L Clinical pharmacokinetics in newborns and infants: Age-related differences and therapeutic implications. Clin Pharmacokinet 1980, 5:485.
21. Notari RE Biopharmaceutics and Clinical Pharmacokinetics 1980, Marcel Dekker, New York. 3rd ed.
22. Peterson RG, Simmons MA, Rumack BH, et al. Pharmacology of furosemide in the premature newborn infant. J Pediatr 1980, 97:139.
23. Physician Insurers Association of America: Medication Error Study. Washington, DC, June 1993.
24. Roberts RJ Drug Therapy in Infants: Pharmacologic Principlesand Clinical Experience 1984, 3. WB Saunders, Philadelphia.
25. Saarenmaa E, Neuvonen PJ, Fellman V Gestational age and girth weight effects on plasma clearance of fentanyl in newborn infants. J Pediatr 2000, 136:67.
26. Santeiro ML, Christie J, Stromquist C, et al. Pharmacokinetics of continuous infusion of fentanyl in newborns. J Perinatol 1997, 17:135.
27. Sheiner LB, Tozer TN Clinical pharmacokinetics: The use of plasma concentrations of drugs. Clinical Pharmacology: Basic Principlesin Therapeutics 1978, 71. Macmillan, New York. 2nd ed. K.L. Melmon, H.F. Morrelli (Eds.).
28. Spector R, Park GD, Johnson GF, et al. Therapeutic drug monitoring. Clin Pharmacol Ther 1988, 43:345.
29. Sutherland JM Fatal cardiovascular collapse, of infants receiving large amounts of chloramphenicol. J Dis Child 1959, 13:761.
30. Ward RM, Singh S, Mirkin BL Fetal clinical pharmacology. Drug Treatment: Principles and Practice of Clinical Pharmacology and Therapeutics 1980, 76. Adis Press, New York. 2nd ed. G.S. Avery (Ed.).
31. Ward RM, Green TP Developmental pharmacology and toxicology: Principles of study design and problems of methodology. Pharmacol Ther 1988, 36:309.
32. Weiss CF, Glazko AJ, Weston JK Chloramphenicol in the newborn infant: A physiologic explanation of its toxicity when given in excessive doses. N Engl J Med 1960, 262:787.